Nebigil C, Malik K U
Department of Pharmacology, College of Medicine, University of Tennessee, Memphis.
J Pharmacol Exp Ther. 1992 Feb;260(2):849-58.
This study was performed to characterize the subtype of adrenergic receptor(s) (AR) involved in prostacyclin synthesis [measured as 6-keto-prostaglandin (PG)F1 alpha] elicited by AR agonists in cultured vascular smooth muscle cells of rabbit aorta. Both alpha-1 and alpha-2 AR agonists enhanced 6-keto-PGF1 alpha synthesis in a dose-dependent manner with the following order of potency: norepinephrine greater than BHT 933 greater than UK 14304 greater than xylazine greater than phenylephrine greater than or equal to methoxamine greater than cirazoline. Isoproterenol and oxymetazoline did not alter 6-keto-PGF1 alpha synthesis. Methoxamine-induced 6-keto-PGF1 alpha synthesis was not reduced by the alpha-2 AR antagonist rauwolscine. The affinities of AR antagonists (PA2 value) in inhibiting methoxamine-induced 6-keto-PGF1 alpha synthesis were of the following order: prazosin greater than WB 4101 greater than corynanthine greater than yohimbine. Administration of WB 4101 and the irreversible alpha-1B AR antagonist chloroethylclonidine reduced norepinephrine (in the presence of rauwolscine, 10(-8) M)- or methoxamine-induced 6-keto-PGF1 alpha synthesis; WB 4101 was more potent than chloroethylclonidine. UK 14304-induced 6-keto-PGF1 alpha synthesis was not reduced by chloroethylclonidine or BRL 44408, a selective alpha-2A AR antagonist, but it was inhibited by other alpha AR antagonists. The affinities of AR antagonists (PA2 values) in inhibiting UK 14304-induced 6-keto-PGF1 alpha synthesis were of the following order: rauwolscine greater than yohimbine greater than BAM 1303 greater than BRL 41992 greater than WB 4101 greater than ARC 239 greater than or equal to prazosin greater than SKF 104078 greater than or equal to corynanthine. The order of affinity of alpha-2 AR antagonists in inhibiting UK 14304-induced 6-keto-PGF1 alpha synthesis in vascular smooth muscle cells was similar to that derived from radioligand binding studies in opossum kidney cell line receptors classified as alpha-2C receptors. These data suggest that 6-keto-PGF1 alpha synthesis elicited by adrenergic stimuli in cultured vascular smooth muscle cells of rabbit aorta is mediated primarily via alpha-2C and to a lesser extent alpha-1A receptors.
本研究旨在确定在兔主动脉培养的血管平滑肌细胞中,参与前列环素合成(以6-酮-前列腺素F1α衡量)的肾上腺素能受体(AR)亚型。α-1和α-2肾上腺素能受体激动剂均以剂量依赖性方式增强6-酮-前列腺素F1α的合成,其效力顺序如下:去甲肾上腺素>BHT 933>UK 14304>赛拉嗪>去氧肾上腺素≥甲氧明>西拉唑啉。异丙肾上腺素和羟甲唑啉未改变6-酮-前列腺素F1α的合成。甲氧明诱导的6-酮-前列腺素F1α合成未被α-2肾上腺素能受体拮抗剂萝芙辛降低。肾上腺素能受体拮抗剂(PA2值)抑制甲氧明诱导的6-酮-前列腺素F1α合成的亲和力顺序如下:哌唑嗪>WB 4101>育亨宾>育亨宾。给予WB 4101和不可逆的α-1B肾上腺素能受体拮抗剂氯乙可乐定可降低去甲肾上腺素(在存在10⁻⁸M萝芙辛的情况下)或甲氧明诱导的6-酮-前列腺素F1α合成;WB 4101比氯乙可乐定更有效。UK 14304诱导的6-酮-前列腺素F1α合成未被氯乙可乐定或选择性α-2A肾上腺素能受体拮抗剂BRL 44408降低,但被其他α肾上腺素能受体拮抗剂抑制。肾上腺素能受体拮抗剂(PA2值)抑制UK 14304诱导的6-酮-前列腺素F1α合成的亲和力顺序如下:萝芙辛>育亨宾>BAM 1303>BRL 41992>WB 4101>ARC 239≥哌唑嗪>SKF 104078≥育亨宾。α-2肾上腺素能受体拮抗剂抑制血管平滑肌细胞中UK 14304诱导的6-酮-前列腺素F1α合成的亲和力顺序与在负鼠肾细胞系受体(归类为α-2C受体)的放射性配体结合研究中得出的顺序相似。这些数据表明,在兔主动脉培养的血管平滑肌细胞中,肾上腺素能刺激引发的6-酮-前列腺素F1α合成主要通过α-2C受体介导,在较小程度上通过α-1A受体介导。